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Purpose: This report describes a case of amaurosis fugax due to a rare primary cardiac sarcoma.
Observations: A patient who was recently diagnosed with left atrial pleomorphic sarcoma presented
with a chief complaint of multiple episodes of intermittent vision loss in the right eye during the course
of radiation therapy.
Conclusions and importance: The authors postulate emboli from the left atrial sarcoma entered systemic
circulation and subsequently caused brief episodes of transient occlusion to retinal, ophthalmic and/or
ciliary arteries leading to momentary retinal hypoxia. We believe this is a novel ﬁnding, previously
unreported in the literature, of transient embolic occlusion without permanent visual sequelae due to a
malignant primary cardiac pleomorphic sarcoma.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Primary cardiac sarcoma is a rare malignancy with a poor
prognosis.1 Due to this rarity, a case of amaurosis fugax caused by
cardiac sarcoma is unusual.2. Case report
A 49 year old male with a past medical history of Hodgkin’s
lymphoma at age 20, hypothyroidism, and recently diagnosed
cardiac sarcoma of the left atrium, presented to our ofﬁce with a
fourmonth history of visual changes in the right eye. Previously, the
patient received treatment for Hodgkin’s lymphoma, ﬁrst with
chemotherapy with carmustine, cyclophosphamide, vinblastine,
prednisone, and procarbazine. Following an incomplete response in
his neck, the patient received mantle ﬁeld and periaortic radio-
therapy for a total dose of 40 Gy.
Regarding ophthalmologic symptoms, he described a “curtain
going over the right eye on and off” resulting in a full graying out of
vision; these episodes occurred occasionally, and occurred for a
duration of four months. This “graying out” would lastn), Katherine.Williams@som.
Inc. This is an open access article uapproximately two minutes in the right eye, then slowly fade away
back to normal vision. Closure of the right eye during the episode
conﬁrmed that the episode was only in the right eye and not a right
homonymous hemianopic ﬁeld defect. He reported the episodes
had been increasing in frequency. He was evaluated by a commu-
nity ophthalmologist at initial onset of symptoms. At that time, no
retinal abnormalities were identiﬁed. The only additional symp-
toms included shortness of breath and intermittent left sided chest
pain; no further symptoms such as claudicationwere identiﬁed. He
was diagnosed with retinal migraines.
After experiencing visual symptoms for four months and
noticing increasing ophthalmologic symptoms, he was found to
have a left atrial sarcoma. Cardiac MRI with and without contrast
revealed an enhancing mass in the posterior left atrium with
extension into the inferior left pulmonary vein without involve-
ment of the mitral valve. The lesion had intermediate signal in-
tensity which measured 4.8 cm in maximum transverse dimension
and 2.1 cm in AP dimension. An MRI brain obtained to further
evaluate for intracranial metastasis showed no evidence of acute
intracranial pathology or metastatic disease.
A trans-septal intracardiac biopsy was performed and surgical
pathology revealed atypical spindle cell proliferation, consistent
with undifferentiated pleomorphic sarcoma. A transthoracic
echocardiogram completed at an outside institution revealed sar-
coma involving the left atrial wall with chronic obstruction of the
left inferior pulmonary vein, with narrowing of the right inferiornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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without obstruction. Functionally, the sarcoma did not involve the
mitral valve.
The rest of the ﬁndings were otherwise within normal limits.
PET/CT scan from skull base to mid thorax further staged the sar-
coma. Metabolic evidence of malignancy correlated to the left atrial
sarcoma with regional subcarinal lymph node involvement. There
was no metabolic evidence of distant metastasis or lymphoma. The
non operable cardiac sarcoma was presumed to be the result of
previous radiation treatment for Hodgkin’s lymphoma.
Following the initiation of daily cardiac radiation for the pleo-
morphic atrial sarcoma, the episodes of amaurosis fugax became a
daily occurrence. At that time, he was referred to our academic
ophthalmology department for evaluation. On the initial examwith
academic ophthalmology, the visual acuity was normal and the
clinical exam revealed no retinal or optic nerve abnormalities;
these ﬁndings were consistent with the exam performed by the
outside community ophthalmologist four months prior. To further
evaluate, a ﬂuorescein angiogram was done to assess for areas of
non-perfusion or delayed circulation time. The angiogram showed
normal circulation time, with no areas of non-perfusion or retinal
ischemia seen in either eye. A complete systemic work up was done
to rule out alternative explanation for the amaurosis fugax. Carotid
Doppler showed no evidence of atherosclerotic disease. Blood work
including ESR and CRP was normal.
Verbal consent was obtained from the patient to describe the
ﬁndings for the literature.
3. Discussion
Amaurosis fugax is often caused by emboli from atherosclerotic
carotid plaques. Hemodynamic abnormalities from vasculitis, such
as giant cell arteritis, vasospasm, atherosclerotic stenosis, hyper-
viscosity, or hypercoagulability can lead to amaurosis fugax.2 In
this case, we hypothesize an atrial mass was releasing cellular
matter into the retinal arterial circulation, resulting in transient
episodes of vision loss. Cardiac vegetations are a less common
source of systemic emboli, and may originate from intracavity
thrombus, cardiac myxoma, and infective endocarditis, as well as
valvular abnormalities including mitral valve prolapse and aortic
valve calciﬁcation.3 Systemic emboli from left heart lesions, in
particular left atrial myxoma, are much more common than pul-
monary emboli with right heart lesions. Cardiac myxoma, a benign
tumor of the heart, occurs in the left heart in approximately 75% of
cases.4 However, malignant cardiac sarcomas are reported with
increased frequency in the right heart, typically in the right
atrium.4
A literature search for previous reports of systemic emboli and
their sequelae in the setting of primary cardiac sarcoma revealed a
two case reports of cerebral ischemia secondary to cardiac tumor
and one case of cardiac chondrosarcoma with visual manifes-
tations.5e7 Cardiac myxomas have been reported to present with
retinal emboli. Reported ophthalmologic manifestations include
unilateral retinal artery occlusion, as well as autopsy proven
myxomatous involvement of choroidal arteries and posterior ciliary
arteries.8,9 Cardiac sarcomas typically occur secondary to metas-
tases; metastatic cardiac tumors are 30 times more likely than a
primary neoplasm.10,11 A study of 75 patients with primary sar-
comas of the heart cited common signs and symptoms of sarcoma
as dyspnea, pain, shortness of breath secondary to pericardial
effusion, chest pain, syncope, or hemoptysis.12 Amaurosis fugax as a
symptom of primary cardiac pleomorphic sarcoma is previously
unpublished in the literature and thus we report a novel ﬁnding.
In our patient, presentation of transient monocular vision loss
occurred without retinal ﬁndings such as Hollenhorst plaques,cottonwool spots, or ﬂame hemorrhages suggestive of emboli from
atherosclerotic disease.13 Carotid Doppler imaging in this patient
was negative for signiﬁcant atherosclerotic stenosis as a potential
cause of amaurosis fugax.14,15 Transient monocular vision loss due
to vascular inﬂammation such as GCA was not consistent with the
presentation in this patient. Although metastasis to the occipital
cortex via the cerebral circulation from the primary cardiac tumor
is possible, no evidence of intracranial pathology or anatomic ab-
normality was found on brain MRI to explain the transient visual
loss in this patient.
Retinal migraines is a diagnosis of exclusion, and was the initial
diagnosis provided to our patient. The patient did not provide a
history of personal migraines, and his episodes were typically
painless. While acephalgic migraines are possible, the lack of per-
sonal history makes retinal migraine unlikely. Moreover, a study of
142 patients with headache and transient monocular vision loss
concluded that the diagnosis of “retinal migraine” was incorrect in
all but 16 patients, with most patients having a secondary cause of
vision loss.16
The ﬁndings on cardiac MRI and biopsy suggest that emboli
from the sarcoma is the most credible cause for amaurosis fugax in
this patient. The increased frequency of episodes following the
initiation cardiac radiotherapy may suggest that with involution of
the tumor, the release of cellular material occurred with increased
frequency. We postulate that emboli from the left atrial sarcoma
entered the systemic circulation. These emboli subsequently
caused transient occlusion to the arteries supplying the optic nerve
inner retina, outer retina and choroid, or watershed zones; this
presented as “graying out” of vision.17 The process of transient
embolic occlusion through the above mentioned process, leaves no
visible evidence of retinal or optic nerve damage on clinical ex-
amination, and has no permanent visual sequela. Clinically, a
retinal artery occlusion has clinical ﬁndings of retinal ischemia in
the form of retinal whitening in the area of vascular distribution,
and angiographic evidence of non-perfusion. Furthermore, there is
irreversible vision loss corresponding to the areas of ischemia.
Our case report details the ﬁrst published incidence of a cardiac
pleomorphic atrial sarcoma as source of emboli to the systemic
circulation to present with ophthalmologic symptoms. The absence
of evidence pointing to common etiologies for transient vision loss
strongly suggests that the sarcoma was the most likely cause of
amaurosis fugax in this patient.References
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